Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Helena J. Van der Pal"'
Autor:
James E. Bates, Tiziana Rancati, Homa Keshavarz, Giovanna Gagliardi, Marianne C. Aznar, Rebecca M. Howell, Suman Shrestha, Vitali Moiseenko, Ellen Yorke, Saro Armenian, Leontien Kremer, Ming Hui Chen, Helena J. van der Pal, David J. Cutter, Louis S. Constine, David Hodgson
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Josien G. M. Beijer, Judith L. Kok, Geert O. Janssens, Nina Streefkerk, Andrica C. H. de Vries, Cleo Slagter, John H. Maduro, Petra S. Kroon, Martha A. Grootenhuis, Eline van Dulmen‐den Broeder, Jacqueline J. Loonen, Markus Wendling, Wim J. E. Tissing, Helena J. van der Pal, Marloes Louwerens, Arjan Bel, Jaap den Hartogh, Margriet van der Heiden‐van der Loo, Leontien C. M. Kremer, Jop C. Teepen, Cécile M. Ronckers
Publikováno v:
Cancer Reports, 6, 2
Beijer, J G M, Kok, J L, Janssens, G O, Streefkerk, N, de Vries, A C H, Slagter, C, Maduro, J H, Kroon, P S, Grootenhuis, M A, van Dulmen-den Broeder, E, Loonen, J J, Wendling, M, Tissing, W J E, van der Pal, H J, Louwerens, M, Bel, A, den Hartogh, J, van der Heiden-van der Loo, M, Kremer, L C M, Teepen, J C & Ronckers, C C M 2023, ' Adverse late health outcomes among children treated with 3D radiotherapy techniques : Study design of the Dutch pediatric 3D-RT study ', Cancer reports (Hoboken, N.J.), vol. 6, no. 2, e1620 . https://doi.org/10.1002/cnr2.1620
Cancer Reports, 6(2). WILEY
Cancer Reports, 6
Cancer reports (Hoboken, N.J.), 6(2):e1620. Wiley-Blackwell Publishing Ltd
Beijer, J G M, Kok, J L, Janssens, G O, Streefkerk, N, de Vries, A C H, Slagter, C, Maduro, J H, Kroon, P S, Grootenhuis, M A, van Dulmen-den Broeder, E, Loonen, J J, Wendling, M, Tissing, W J E, van der Pal, H J, Louwerens, M, Bel, A, den Hartogh, J, van der Heiden-van der Loo, M, Kremer, L C M, Teepen, J C & Ronckers, C C M 2023, ' Adverse late health outcomes among children treated with 3D radiotherapy techniques : Study design of the Dutch pediatric 3D-RT study ', Cancer reports (Hoboken, N.J.), vol. 6, no. 2, e1620 . https://doi.org/10.1002/cnr2.1620
Cancer Reports, 6(2). WILEY
Cancer Reports, 6
Cancer reports (Hoboken, N.J.), 6(2):e1620. Wiley-Blackwell Publishing Ltd
Contains fulltext : 291345.pdf (Publisher’s version ) (Open Access) BACKGROUND: Adverse late health outcomes after multimodal treatment for pediatric cancer are diverse and of prime interest. Currently available evidence and survivorship care guide
Autor:
Demi T.C. de Winter, Jenneke E. Van Atteveld, Vincent G. Pluimakers, Marta Fiocco, Rutger A.J. Nievelstein, Monique G.G. Hobbelink, Andrica C.H. de Vries, Jacqueline J. Loonen, Eline Van Dulmen-den Broeder, Helena J. van der Pal, Saskia M.F. Pluijm, Leontien C.M. Kremer, Cécile M. Ronckers, Margriet van der Heiden-van der Loo, Birgitta Versluys, Marloes Louwerens, Dorine Bresters, Hanneke M. van Santen, Daniel S. Olsson, Imo Hoefer, Sjoerd A.A. van den Berg, Jaap den Hartogh, Wim J.E. Tissing, Sebastian J.C.M.M. Neggers, Marry M. van den Heuvel-Eibrink
Publikováno v:
Blood. 140:922-923
Autor:
Elske Sieswerda, Anna Font-Gonzalez, Johannes B Reitsma, Marcel G W Dijkgraaf, Richard C Heinen, Monique W Jaspers, Helena J van der Pal, Flora E van Leeuwen, Huib N Caron, Ronald B Geskus, Leontien C Kremer
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159518 (2016)
Hospitalization rates over time of childhood cancer survivors (CCS) provide insight into the burden of unfavorable health conditions on CCS and health care resources. The objective of our study was to examine trends in hospitalizations of CCS and ris
Externí odkaz:
https://doaj.org/article/e41d6e8d354c424eb0bbbe8f2d6ea9fe
Autor:
M. E. Madeleine van der Perk, Linda Broer, Yutaka Yasui, Leslie L. Robison, Melissa M. Hudson, Joop S. E. Laven, Helena J. van der Pal, Wim J. E. Tissing, Birgitta Versluys, Dorine Bresters, Gertjan J. L. Kaspers, Andrica C. H. de Vries, Cornelis B. Lambalk, Annelies Overbeek, Jacqueline J. Loonen, Catharina C. M. Beerendonk, Julianne Byrne, Claire Berger, Eva Clemens, Uta Dirksen, Jeanette Falck Winther, Sophie D. Fosså, Desiree Grabow, Monica Muraca, Melanie Kaiser, Tomáš Kepák, Jarmila Kruseova, Dalit Modan-Moses, Claudia Spix, Oliver Zolk, Peter Kaatsch, Jesse H. Krijthe, Leontien C. M. Kremer, Russell J. Brooke, Jessica L. Baedke, Ron H. N. van Schaik, John N. van den Anker, André G. Uitterlinden, Annelies M. E. Bos, Flora E. van Leeuwen, Eline van Dulmen-den Broeder, Anne-Lotte L. F. van der Kooi, Marry M. van den Heuvel-Eibrink, on behalf of the PanCareLIFE Consortium
Publikováno v:
Cancers, 13(18)
Van Der Perk, M E M, Broer, L, Yasui, Y, Robison, L L, Hudson, M M, Laven, J S E, Van Der Pal, H J, Tissing, W J E, Versluys, B, Bresters, D, Kaspers, G J L, De Vries, A C H, Lambalk, C B, Overbeek, A, Loonen, J J, Beerendonk, C C M, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Winther, J F, Fosså, S D, Grabow, D, Muraca, M, Kaiser, M, Kepák, T, Kruseova, J, Modan-Moses, D, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C M, Brooke, R J, Baedke, J L, Van Schaik, R H N, Van Den Anker, J N, Uitterlinden, A G, Bos, A M E, Van Leeuwen, F E, Van Dulmen-Den Broeder, E, Van Der Kooi, A L L F, Van Den Heuvel-Eibrink, M M & The PanCareLIFE consortium 2021, ' Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach : Results from the pancareLIFE study ', Cancers, vol. 13, no. 18, 4598 . https://doi.org/10.3390/cancers13184598
Cancers, Vol 13, Iss 4598, p 4598 (2021)
Cancers, 13(18):4598. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 13
Issue 18
Cancers, 13
The PanCareLIFE Consortium 2021, ' Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: Results from the pancareLIFE study ', Cancers, vol. 13, no. 18, 4598 . https://doi.org/10.3390/cancers13184598
Cancers, 13, 18
Van Der Perk, M E M, Broer, L, Yasui, Y, Robison, L L, Hudson, M M, Laven, J S E, Van Der Pal, H J, Tissing, W J E, Versluys, B, Bresters, D, Kaspers, G J L, De Vries, A C H, Lambalk, C B, Overbeek, A, Loonen, J J, Beerendonk, C C M, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Winther, J F, Fosså, S D, Grabow, D, Muraca, M, Kaiser, M, Kepák, T, Kruseova, J, Modan-Moses, D, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C M, Brooke, R J, Baedke, J L, Van Schaik, R H N, Van Den Anker, J N, Uitterlinden, A G, Bos, A M E, Van Leeuwen, F E, Van Dulmen-Den Broeder, E, Van Der Kooi, A L L F, Van Den Heuvel-Eibrink, M M & The PanCareLIFE consortium 2021, ' Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach : Results from the pancareLIFE study ', Cancers, vol. 13, no. 18, 4598 . https://doi.org/10.3390/cancers13184598
Cancers, Vol 13, Iss 4598, p 4598 (2021)
Cancers, 13(18):4598. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 13
Issue 18
Cancers, 13
The PanCareLIFE Consortium 2021, ' Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: Results from the pancareLIFE study ', Cancers, vol. 13, no. 18, 4598 . https://doi.org/10.3390/cancers13184598
Cancers, 13, 18
Background: Female childhood cancer survivors (CCSs) carry a risk of therapy-related gonadal dysfunction. Alkylating agents (AA) are well-established risk factors, yet inter-individual variability in ovarian function is observed. Polymorphisms in CYP
Autor:
Elske Sieswerda, Anna Font-Gonzalez, Marcel G W Dijkgraaf, Ronald B Geskus, Richard C Heinen, Helena J van der Pal, Flora E van Leeuwen, Huib N Caron, Leontien C Kremer, Johannes B Reitsma
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132444 (2015)
In the Netherlands, the postal code is needed to study hospitalizations of individuals in the nationwide hospitalization register. Studying hospitalizations longitudinally becomes troublesome if individuals change address. We aimed to report on the f
Externí odkaz:
https://doaj.org/article/4840b81e38a9499a893ff93fb18ee7fd
Autor:
Elizabeth Lieke A M Feijen, Helena J van der Pal, Elvira C van Dalen, Renee L Mulder, Edit Bardi, Claudia Kuehni, Wim J E Tissing, Leontine C M Kremer
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e100432 (2014)
BackgroundCardiac events (CEs) are among the most serious late effects following childhood cancer treatment. To establish accurate risk estimates for the occurrence of CEs it is essential that they are graded in a valid and consistent manner, especia
Externí odkaz:
https://doaj.org/article/ede7eeee1dca4ec0baf0d6178f482af1
Autor:
Vincent G. Pluimakers, Jenneke E. Van Atteveld, Demi T.C. de Winter, Marta Fiocco, Rutger A.J. Nievelstein, Dorine Bresters, Margriet Van der Heiden-Van der Loo, Andrica de Vries, Geert O Janssens, Marloes Louwerens, Helena J. Van der Pal, Cecile M. Ronckers, Hanneke M. Van Santen, Birgitta Versluys, Leontien Kremer, Jacqueline J. Loonen, Wim J.E. Tissing, Eline Van Dulmen-Den Broeder, Marry M. van den Heuvel-Eibrink, Sebastian J.C.M.M. Neggers
Publikováno v:
Blood. 138:3054-3054
BACKGROUND Overweight is a common problem in the general population, but occurs more frequently among childhood cancer survivors (CCS) and is regarded as a late adverse effect. However, risk factors are not fully elucidated and it is often disguised
Autor:
Henk, Visscher, S Rod, Rassekh, George S, Sandor, Huib N, Caron, Elvira C, van Dalen, Leontien C, Kremer, Helena J, van der Pal, Paul C, Rogers, Michael J, Rieder, Bruce C, Carleton, Michael R, Hayden, Colin J, Ross, Norma, Kean
Publikováno v:
Pharmacogenomics, 16(10), 1065-1076. Future Medicine Ltd.
Aim: To identify novel variants associated with anthracycline-induced cardiotoxicity and to assess these in a genotype-guided risk prediction model. Patients & methods: Two cohorts treated for childhood cancer (n = 344 and 218, respectively) were gen
Autor:
Henk, Visscher, Colin J D, Ross, S Rod, Rassekh, Amina, Barhdadi, Marie-Pierre, Dubé, Hesham, Al-Saloos, George S, Sandor, Huib N, Caron, Elvira C, van Dalen, Leontien C, Kremer, Helena J, van der Pal, Andrew M K, Brown, Paul C, Rogers, Michael S, Phillips, Michael J, Rieder, Bruce C, Carleton, Michael R, Hayden
Publikováno v:
Journal of clinical oncology, 30(13), 1422-1428. American Society of Clinical Oncology
Purpose Anthracycline-induced cardiotoxicity (ACT) is a serious adverse drug reaction limiting anthracycline use and causing substantial morbidity and mortality. Our aim was to identify genetic variants associated with ACT in patients treated for chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95bc94c537229713b8e805e278b8f71
https://pure.amc.nl/en/publications/pharmacogenomic-prediction-of-anthracyclineinduced-cardiotoxicity-in-children(7448d4cc-8830-4faf-a3b6-5de6ff57acab).html
https://pure.amc.nl/en/publications/pharmacogenomic-prediction-of-anthracyclineinduced-cardiotoxicity-in-children(7448d4cc-8830-4faf-a3b6-5de6ff57acab).html